Revolutionary Genome Sequencing Technologies -- the $1000 Genome

The summary for the Revolutionary Genome Sequencing Technologies -- the $1000 Genome grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Revolutionary Genome Sequencing Technologies -- the $1000 Genome: The purpose of this Request for Applications (RFA) is to solicit grant applications to develop novel technologies that will enable extremely low-cost genomic DNA sequencing. Current technologies are able to produce the sequence of a mammalian-sized genome of the desired data quality for $10 to $50 million; the goal of this initiative is to reduce costs by at least four orders of magnitude, so that a mammalian- sized genome could be sequenced for approximately $1000. Substantial fundamental research is needed to develop the scientific and technological knowledge underpinning such a major advance. Therefore, it is anticipated that the realization of the goals of this RFA is a long-range effort that is likely to require as much as ten years to achieve. A parallel RFA HG-04-002 (http://grants.nih.gov/grants/guide/rfa-files/RFA-HG-04-002.html) solicits grant applications to develop technologies to meet the shorter-term goal of achieving two-orders of magnitude cost reduction in about five years.

Federal Grant Title:	Revolutionary Genome Sequencing Technologies -- the $1000 Genome
Federal Agency Name:	National Institutes of Health
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-HG-04-003
Type of Funding:	Grant
CFDA Numbers:	93.172
CFDA Descriptions:	Human Genome Research
Current Application Deadline:	No deadline provided
Original Application Deadline:	April 15, 2004, October 14, 2004
Posted Date:	Feb 17, 2004
Creation Date:	Feb 17, 2004
Archive Date:	Nov 13, 2004
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: State governments County governments City or township governments Special district governments Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses Small businesses
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [email protected] NIH OER Webmaster
Similar Government Grants: • Ethical, Legal, and Social Implications (ELSI) Congress (U13, Clinical Trials Not Allowed); • SBIR Solutions to Enable Population Genomic Screening (R43/R44 Clinical Trial Optional); • STTR Solutions to Enable Population Genomic Screening (R41/R42 Clinical Trial Optional); • Population Genomic Screening in Primary Care Sequencing Center (U01 - Clinical Trial Optio...; • Population Genomic Screening in Primary Care Cooperative Agreement (U01 - Clinical Trial R...; • Near-Term Technology Development for Genome Sequencing - SBIR (R43/R44); • Near-Term Technology Development for Genome Sequencing - STTR (R41/R42); • Revolutionary Genome Sequencing Technologies - The $1000 Genome - SBIR (R43/R44)
More Grants from the National Institutes of Health: • Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed...; • Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional); • NIA Advanced Postdoctoral Career Transition Awards to Promote Diversity in Translational R...; • Clinical and Translational Science Award (UM1 Clinical Trial Optional); • Tribal Undergraduate to Graduate Research Training and Leadership Experiences (TURTLE) Pro...